HIF hydroxylation and the mammalian oxygen-sensing pathway.
作者信息
Safran Michal, Kaelin William G
机构信息
Howard Hughes Medical Institute, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, Massachusetts 02115, USA.
出版信息
J Clin Invest. 2003 Mar;111(6):779-83. doi: 10.1172/JCI18181.
Abstract
摘要
相似文献
1
HIF hydroxylation and the mammalian oxygen-sensing pathway.
J Clin Invest. 2003 Mar;111(6):779-83. doi: 10.1172/JCI18181.
2
Regulation of HIF by the von Hippel-Lindau tumour suppressor: implications for cellular oxygen sensing.
IUBMB Life. 2001 Jul;52(1-2):43-7. doi: 10.1080/15216540252774757.
3
Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function.
Oncogene. 2000 Nov 16;19(48):5435-43. doi: 10.1038/sj.onc.1203938.
4
Much huffing about HIF: oxygen dependent proline hydroxylation and the regulation of hypoxia inducible factors.
Pediatr Res. 2001 Dec;50(6):673. doi: 10.1203/00006450-200112000-00003.
5
Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation.
Science. 2001 Apr 20;292(5516):468-72. doi: 10.1126/science.1059796. Epub 2001 Apr 5.
6
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis.
Nature. 1999 May 20;399(6733):271-5. doi: 10.1038/20459.
7
Hypoxia inducible factor-alpha binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein.
J Biol Chem. 2000 Aug 18;275(33):25733-41. doi: 10.1074/jbc.M002740200.
8
Cancer. Many vessels, faulty gene.
Nature. 1999 May 20;399(6733):203-4. doi: 10.1038/20309.
9
The von Hippel-Lindau tumor suppressor, hypoxia-inducible factor-1 (HIF-1) degradation, and cancer pathogenesis.
Semin Cancer Biol. 2003 Feb;13(1):83-9. doi: 10.1016/s1044-579x(02)00103-7.
10
Molecular targets from VHL studies into the oxygen-sensing pathway.
Curr Cancer Drug Targets. 2005 Aug;5(5):345-56. doi: 10.2174/1568009054629672.
引用本文的文献
1
Distinct Stress Regulators in the CRL Family: Emerging Roles of F-Box Proteins: Cullin-RING Ligases and Stress-Sensing.
Bioessays. 2025 May;47(5):e202400249. doi: 10.1002/bies.202400249. Epub 2025 Mar 16.
2
GPR1 and CMKLR1 Control Lipid Metabolism to Support the Development of Clear Cell Renal Cell Carcinoma.
Cancer Res. 2024 Jul 2;84(13):2141-2154. doi: 10.1158/0008-5472.CAN-23-2926.
3
HIF1α-dependent uncoupling of glycolysis suppresses tumor cell proliferation.
Cell Rep. 2024 Apr 23;43(4):114103. doi: 10.1016/j.celrep.2024.114103. Epub 2024 Apr 11.
4
ROS production by mitochondria: function or dysfunction?
Oncogene. 2024 Jan;43(5):295-303. doi: 10.1038/s41388-023-02907-z. Epub 2023 Dec 11.
5
Structure-guided optimisation of -hydroxythiazole-derived inhibitors of factor inhibiting hypoxia-inducible factor-α.
Chem Sci. 2023 Oct 27;14(43):12098-12120. doi: 10.1039/d3sc04253g. eCollection 2023 Nov 8.
6
Medium Depth Influences O2 Availability and Metabolism in Human RPE Cultures.
Invest Ophthalmol Vis Sci. 2023 Nov 1;64(14):4. doi: 10.1167/iovs.64.14.4.
7
The anaemia treatment journey of CKD patients: from epoetins to hypoxia-inducible factor-prolyl hydroxylase inhibitors.
Clin Kidney J. 2023 Aug 17;16(10):1563-1579. doi: 10.1093/ckj/sfad105. eCollection 2023 Oct.
8
Fumarate hydratase (FH) and cancer: a paradigm of oncometabolism.
Br J Cancer. 2023 Nov;129(10):1546-1557. doi: 10.1038/s41416-023-02412-w. Epub 2023 Sep 9.
9
Increased transferrin protects from thrombosis in Chuvash erythrocytosis.
Am J Hematol. 2023 Oct;98(10):1532-1539. doi: 10.1002/ajh.27021. Epub 2023 Jul 12.
10
Regulatory Functions of Hypoxia in Host-Parasite Interactions: A Focus on Enteric, Tissue, and Blood Protozoa.
Microorganisms. 2023 Jun 16;11(6):1598. doi: 10.3390/microorganisms11061598.
本文引用的文献
1
Biochemical purification and pharmacological inhibition of a mammalian prolyl hydroxylase acting on hypoxia-inducible factor.
Proc Natl Acad Sci U S A. 2002 Oct 15;99(21):13459-64. doi: 10.1073/pnas.192342099. Epub 2002 Sep 26.
2
The contribution of VHL substrate binding and HIF1-alpha to the phenotype of VHL loss in renal cell carcinoma.
Cancer Cell. 2002 Apr;1(3):247-55. doi: 10.1016/s1535-6108(02)00044-2.
3
Inhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau protein.
Cancer Cell. 2002 Apr;1(3):237-46. doi: 10.1016/s1535-6108(02)00043-0.
4
FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor.
Genes Dev. 2002 Jun 15;16(12):1466-71. doi: 10.1101/gad.991402.
5
Structural basis for the recognition of hydroxyproline in HIF-1 alpha by pVHL.
Nature. 2002 Jun 27;417(6892):975-8. doi: 10.1038/nature00767. Epub 2002 Jun 5.
6
Hypoxia-inducible factor (HIF) asparagine hydroxylase is identical to factor inhibiting HIF (FIH) and is related to the cupin structural family.
J Biol Chem. 2002 Jul 19;277(29):26351-5. doi: 10.1074/jbc.C200273200. Epub 2002 May 31.
7
Structure of an HIF-1alpha -pVHL complex: hydroxyproline recognition in signaling.
Science. 2002 Jun 7;296(5574):1886-9. doi: 10.1126/science.1073440. Epub 2002 May 9.
8
Structural basis for recruitment of CBP/p300 by hypoxia-inducible factor-1 alpha.
Proc Natl Acad Sci U S A. 2002 Apr 16;99(8):5367-72. doi: 10.1073/pnas.082117899.
9
Structural basis for Hif-1 alpha /CBP recognition in the cellular hypoxic response.
Proc Natl Acad Sci U S A. 2002 Apr 16;99(8):5271-6. doi: 10.1073/pnas.082121399.
10
Asparagine hydroxylation of the HIF transactivation domain a hypoxic switch.
Science. 2002 Feb 1;295(5556):858-61. doi: 10.1126/science.1068592.
Zotero 插件